Wave Life Sciences (WVE)
Preço: 5.87Empresa e modelo de negócios
Wave Life Sciences is a biotechnology company focused on developing therapies for genetic diseases. Its core products include RNA-targeted medicines, with a primary emphasis on treating conditions such as Duchenne muscular dystrophy and other rare diseases. The company operates in the healthcare sector, generating revenue primarily through research and development collaborations and potential future product sales.
Perfil de investimento
The investment profile of Wave Life Sciences is more aligned with growth investors due to its focus on innovative therapies and potential for significant revenue increases. However, the high risk associated with its current financial performance and market volatility suggests caution. The stock may appeal to those with a medium to long-term investment horizon who are comfortable with higher risk levels.
Métricas fundamentais (experimental)
- EPS (TTM) — lucro por ação dos últimos 12 meses, $
- -1.06 Risco
- Receita QoQ — crescimento da receita trimestre contra trimestre
- 121.8% ↑
- Surpresa de EPS
- 61.8% melhor que o esperado
- Volatilidade 20d
- 3.5% estável
Impacto da previsão
positivoAcompanhar no portfólio
Gráfico de preço
| Data | Antes | Depois | Motivo |
|---|---|---|---|
| 2026-05-28 03:37 | Manter | Vender | scenario_deterioration |
| 2026-05-24 02:55 | Vender | Manter | Weak fundamentals and negative momentum raise significant risk. |
| 2026-05-08 15:20 | — | Vender | Weak momentum and high risk offset potential gains. |
| Data | Analista | Action | Alvo | Preço na época |
|---|---|---|---|---|
| 2026-06-11 10:43 | New Street | Atualizar | — → 13 | 5.66 |
| 2026-05-20 10:29 | Wells Fargo | Preço-alvo elevado | 13 → 14 | 6.14 |
| 2026-05-19 10:44 | H.C. Wainwright | Preço-alvo reduzido | 18 → 13 | 6.4 |
Nada ainda